Ray Dalio
INSM icon

Ray Dalio’s Insmed INSM Stock Holding History

Ray Dalio’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.3M Buy
+295,579
New +$45.4M 0.22% 78

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ray Dalio's INSM Position: Q1 2026 in Review

Ray Dalio opened a new position in Insmed (INSM) in Q1 2026: 295,579 shares worth $48.3M. The stake represents 0.22% of the portfolio and ranks #78 among its holdings.

672 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Ray Dalio held 295,579 shares of Insmed worth $48.3M as of Q1 2026.
  • Insmed was a new Ray Dalio position in Q1 2026.
  • Insmed made up 0.22% of Ray Dalio's portfolio in Q1 2026, its #78 holding.
  • 672 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.